Trial Profile

BCG vaccination to Reduce the impact of COVID-19 in healthcare workers following Coronavirus Exposure (BRACE) Trial

Status: Completed

Phase of Trial: Phase III

Latest Information Update: 26 Sep 2024

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs BCG vaccine (Primary)
Indications COVID 2019 infections
Focus Adverse reactions
Acronyms BRACE

Most Recent Events

01 Jun 2024 Results (n=1985) assessing the effect of vaccination with BCG-Denmark to prevent initial and sustained interferon-gamma release assay conversion in Brazilian health-care workers published in The Lancet Infectious Diseases
27 Apr 2023 Results (n=3988) published in the New England Journal of Medicine
12 Jul 2022 Status changed from active, no longer recruiting to completed.

You need to be a logged in or subscribed to view this content

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com